MARKET

PHAT

PHAT

Phathom Pharmaceuticals, Inc.
NASDAQ
4.110
-0.010
-0.24%
After Hours: 4.127 +0.017 +0.41% 19:08 04/25 EDT
OPEN
4.050
PREV CLOSE
4.120
HIGH
4.130
LOW
3.960
VOLUME
875.75K
TURNOVER
--
52 WEEK HIGH
19.71
52 WEEK LOW
3.810
MARKET CAP
286.21M
P/E (TTM)
-0.7766
1D
5D
1M
3M
1Y
5Y
1D
PHATHOM PHARMACEUTICALS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON THURSDAY, MAY 1, 2025
Reuters · 4d ago
Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham
Dow Jones · 6d ago
Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $28 Price Target
Benzinga · 6d ago
Analysts’ Top Healthcare Picks: Medtronic (MDT), UnitedHealth (UNH)
TipRanks · 6d ago
Weekly Report: what happened at PHAT last week (0414-0418)?
Weekly Report · 6d ago
Why We're Not Concerned Yet About Phathom Pharmaceuticals, Inc.'s (NASDAQ:PHAT) 27% Share Price Plunge
Simply Wall St · 04/18 11:00
Phathom Pharmaceuticals Is Maintained at Neutral by Goldman Sachs
Dow Jones · 04/17 17:53
Phathom Pharmaceuticals Appoints Theodore Schroeder to Board
TipRanks · 04/16 12:28
More
About PHAT
More
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s product candidates include VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker, or potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.
Recently
Symbol
Price
%Change

Webull offers Phathom Pharmaceuticals Inc stock information, including NASDAQ: PHAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAT stock methods without spending real money on the virtual paper trading platform.